| Authors: |
Grillo G; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; T-One Therapeutics, Milan, Italy., Nadorp B; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Bristol Myers Squibb, Princeton, NJ, USA., Qamra A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Hoffman-La Roche, Mississauga, Ontario, Canada., Drylie B; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, UK.; Centre for Epigenetics, Queen Mary University of London, London, UK., Mitchell A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Arlidge C; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Nand A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Takayama N; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Murison A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Madani Tonekaboni SA; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Kang KK; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Arruda A; Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Ontario, Canada., Wang JCY; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Minden MD; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Deniz Ö; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, UK.; Centre for Epigenetics, Queen Mary University of London, London, UK., Boutzen H; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Dick JE; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. john.dick@uhn.ca.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. john.dick@uhn.ca., Lupien M; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. mathieu.lupien@uhn.ca.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. mathieu.lupien@uhn.ca.; Ontario Institute for Cancer Research, Toronto, Ontario, Canada. mathieu.lupien@uhn.ca. |
